Latest news
ENTX: FDA-aligned Phase 3 for EB613 and $275M financing secure pipeline progress and cash runway - TradingViewTradingView · Fri, 07 Aug 2026 20:15:54 GMTTonix Gets FDA Alignment on TNX-4800 Phase 2 Lyme Disease Study Design - The Clinical Trial VanguardThe Clinical Trial Vanguard · Wed, 05 Aug 2026 06:33:35 GMTLRMR: Nomlabofusp advances toward approval with positive clinical data, FDA alignment, and strong cash runway - TradingViewTradingView · Tue, 04 Aug 2026 11:07:34 GMTTonix Pharmaceuticals Announces FDA Alignment on 3,300‑Participant Adaptive Phase 2 Lyme Study; TNX-4800 Dosing, 2027 Site Delivery - TradingViewTradingView · Mon, 03 Aug 2026 11:23:01 GMTTonix Pharmaceuticals Announces FDA Alignment on Phase 2 Study Design for TNX-4800 Lyme Disease Prevention Trial - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMTHow Investors Are Reacting To Disc Medicine (IRON) Balancing Larger Losses With APOLLO Phase 3 FDA Alignment - webull.comwebull.com · Sun, 02 Aug 2026 01:45:52 GMTWedbush Initiates Benitec At Outperform Rating; $16 PT; Benitec Expects FDA Alignment In Mid 2026; - RTTNewsRTTNews · Wed, 29 Jul 2026 13:43:00 GMTCalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints - PR NewswirePR Newswire · Wed, 29 Jul 2026 07:00:00 GMT